ClinicalTrials.Veeva

Menu

Chronic Arterial Disease, Quality of Life and Mortality in Chronic Kidney Injury (CADKID)

T

Turku University Hospital (TYKS)

Status

Active, not recruiting

Conditions

Kidney Diseases
Cardiovascular Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT04223726
T41/2013

Details and patient eligibility

About

CADKID-study is a prospective follow-up study assessing arterial disease, quality of life, mortality and their predictors in patients with severe chronic kidney disease.

Full description

Chronic kidney disease (CKD) is associated with increased risk of cardiovascular disease and mortality as well as impaired quality of life. Participants of this study all have severe CKD, defined as estimated glomerular filtration rate < 30 ml/min per 1.73 m^2. Stress ergometry, echocardiography, ultrasound assessment of arterial intima-media thickness, lateral lumbar radiograph, ECG, laboratory tests and quality of life assessment were performed at the baseline of the study and will be repeated during follow-up. Atrial fibrillation and other cardiac arrhythmias as well as pulse wave velocity measurements will be explored. Diet diaries are gathered and analysed. The aim of the study is to identify factors associated with cardiovascular disease, quality of life and mortality in this cohort.

Enrollment

210 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • estimated glomerular filtration rate < 30 ml/min per 1.73 m^2

Exclusion criteria

  • age under 18 years
  • inability to give informed consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems